FRAXION Spinal Fixation System
Ortler Global Tibbi Gerecler Anonim Sirketi · Decision date Sep 17, 2026
What did the FDA decide?
The FDA's 510(k) record K262091 covers the FRAXION Spinal Fixation System, submitted by Ortler Global Tibbi Gerecler Anonim Sirketi of Ankara, Turkey. The device falls under the Thoracolumbosacral Pedicle Screw System classification, regulation number 888.3070, with primary product code NKB and subsequent codes KWP and KWQ; the regulation medical specialty and review panel are both listed as Orthopedic. The application was received on 06/22/2026 as a Traditional 510(k), was not reviewed by a third party, and was not a combination product.
On 09/17/2026 the FDA recorded a decision of Substantially Equivalent (SESE), which for a 510(k) means clearance to market rather than premarket approval. The record does not include a summary statement, so the specific predicates cited, the components or changes assessed, and any performance data supporting equivalence are not available here. No predetermined change control plan was authorized.
Because the underlying review documentation is absent from this source, the basis for the equivalence finding and any device-specific limitations remain unknown and should be confirmed against the full FDA record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 17, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262091
- Regulatory pathway
- 510(k) premarket notification
- Product code
- NKB
- Decision code
- SESE
- Decision date
- Sep 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Thoracolumbosacral Pedicle Screw System.
- Product code
- NKB
- FDA device class
- 2
FDA decision timeline
K262091 received
Application receipt date recorded by FDA.
K262091 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NKB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| SeaSpine Orthopedics Corporation | 510(k) clearance | Oct 29, 2026 | FDA | |
| GS Medical Co., Ltd. | 510(k) clearance | Oct 2, 2026 | FDA | |
NOVIX Pedicle Screw SystemK263062 | Tdm Co., Ltd. | 510(k) clearance | Oct 1, 2026 | FDA |
Duet Spinal Fixation SystemK262712 | Duet Spine Holdings, LLC | 510(k) clearance | Sep 30, 2026 | FDA |
| Spinal Alignment Solutions, Inc. | 510(k) clearance | Sep 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Ortler Global Tibbi Gerecler Anonim Sirketi
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Ankara
Sources and methodology
- Original FDA record: K262091
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


